KR890005107A - 약제 제조를 위한 특정 6-머캅토푸린의 용도 및 이 약제의 제조방법 - Google Patents
약제 제조를 위한 특정 6-머캅토푸린의 용도 및 이 약제의 제조방법 Download PDFInfo
- Publication number
- KR890005107A KR890005107A KR1019880011637A KR880011637A KR890005107A KR 890005107 A KR890005107 A KR 890005107A KR 1019880011637 A KR1019880011637 A KR 1019880011637A KR 880011637 A KR880011637 A KR 880011637A KR 890005107 A KR890005107 A KR 890005107A
- Authority
- KR
- South Korea
- Prior art keywords
- compounds
- medicaments
- manufacture
- medicament
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (4)
- 리트로바이러스에 의해 발병된 질환의 치료 약제를 제조하기 위한 일반식(Ⅰ) 화합물의 용도(Ⅰ)상기식에서, R1은 H,NH2,NHR1'(R1'은 치환된 아실 라디칼, 바람직하게는 COCH3이다)이고, R2는 H또는이며, X는 O 또는 S이고, R3는 H, 임의로 1개의 이중결합을 갖는 지방족C1-C6-탄화수소 라디칼, CH1-C6H5또는 COR4이며, R4는 C1-C6-알킬 라디칼, CH2-C6H5또는 C6H5이며, R5는 H또는 CH2-Y이며, Y는 H, 할로겐 또는 OR6이고, R6는 R3와 독립적이며 R와는 동일한 정의의 의미를 가지고, 단, 상기 일반식(Ⅰ)화합물중에서, (a) R1은 NH2이고, R5(R2중의)는 CH2-Y이며, Y는 할로겐 또는 OR6이고, R6는 임의로 1개의 이중 결합을 갖는 지방족 C1-C6-탄화수소 라디칼 또는 CH2-C6H5인 화합물 밑 (b) R1은 H이고, R2는이며,X는 O또는 S이고, R3는 H,i-C3H7,S-C4H9,CH2-C6H5또는 COR4이며, R4가 CH3,C6H5또는 C6H5이고, R5는 H,CH2OC3H7(i),고 CH2OC4H9(S) 또는 CH2OCOR4인 화합물은 제외하며, R1,R3및 R5가 동시에 H인 화합물은 제외되지 않는다.
- 제 1 항에 있어서, 리트로바이러스가 HIV인 용도.
- 제 1 항 또는 제 2 항에 있어서, 적어도 하나의 일반식(Ⅰ) 화합물 약 30 내지 300mg, 바람직하게는 약 50내지 250mg의 용량 단위를 갖는 약제를 제조하기 위한 용도.
- 유효량의 일반식(Ⅰ)(청구범위 1에서 정의됨) 화합물 하나이상을 생리학적으로 허용되는 통상의 첨가제와 함께 적합한 용량형으로 전환시킴을 특징으로 하여, 리크로바이러스, 특히 HIV에 의해 발병된 질환을 치료하기 위한 약제를 제조하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP3730541.7 | 1987-09-11 | ||
DE19873730541 DE3730541A1 (de) | 1987-09-11 | 1987-09-11 | Verwendung bestimmter 6-mercaptopurine zur herstellung eines arzneimittels sowie verfahren zur herstellung des arzneimittels |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890005107A true KR890005107A (ko) | 1989-05-11 |
Family
ID=6335790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880011637A KR890005107A (ko) | 1987-09-11 | 1988-09-09 | 약제 제조를 위한 특정 6-머캅토푸린의 용도 및 이 약제의 제조방법 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0306844A2 (ko) |
JP (1) | JPH01100123A (ko) |
KR (1) | KR890005107A (ko) |
AU (1) | AU2203888A (ko) |
DE (1) | DE3730541A1 (ko) |
DK (1) | DK501788A (ko) |
HU (1) | HUT47851A (ko) |
PT (1) | PT88455A (ko) |
ZA (1) | ZA886675B (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9015051D0 (en) * | 1990-07-07 | 1990-08-29 | Beecham Group Plc | Pharmaceutical treatment |
WO2002081472A1 (fr) * | 2001-04-05 | 2002-10-17 | Sumika Fine Chemicals Co., Ltd. | Procede de production de 2,6-dihalogenopurine |
-
1987
- 1987-09-11 DE DE19873730541 patent/DE3730541A1/de not_active Withdrawn
-
1988
- 1988-09-02 EP EP88114312A patent/EP0306844A2/de not_active Withdrawn
- 1988-09-08 PT PT88455A patent/PT88455A/pt not_active Application Discontinuation
- 1988-09-08 ZA ZA886675A patent/ZA886675B/xx unknown
- 1988-09-09 JP JP63224822A patent/JPH01100123A/ja active Pending
- 1988-09-09 AU AU22038/88A patent/AU2203888A/en not_active Abandoned
- 1988-09-09 HU HU884649A patent/HUT47851A/hu unknown
- 1988-09-09 KR KR1019880011637A patent/KR890005107A/ko not_active Application Discontinuation
- 1988-09-09 DK DK501788A patent/DK501788A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK501788A (da) | 1989-03-12 |
HUT47851A (en) | 1989-04-28 |
JPH01100123A (ja) | 1989-04-18 |
PT88455A (pt) | 1989-07-31 |
DK501788D0 (da) | 1988-09-09 |
AU2203888A (en) | 1989-03-16 |
EP0306844A2 (de) | 1989-03-15 |
DE3730541A1 (de) | 1989-04-06 |
ZA886675B (en) | 1989-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK275488D0 (da) | Indolonderivater | |
FR2387941A1 (fr) | Homologue de la somatostatine, ses intermediaires de preparation, et son utilisation comme medicament | |
ATE115958T1 (de) | Nukleoside und nukleosid-analoge, pharmazeutische zusammensetzung und verfahren für die herstellung der bestandteile. | |
SE8402551D0 (sv) | Cinnamoylmoranolin-derivat | |
ES8609325A1 (es) | Un procedimiento para preparar derivados de guanina | |
DE68901153D1 (de) | Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung. | |
FR2361901A1 (fr) | Derives de substitution de nucleotides et medicament contenant ces substances | |
SE8703854D0 (sv) | Prostaglandinderivat for behandling av glaukom eller okuler hypertension | |
FR2438654A1 (fr) | Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose | |
ES8505379A1 (es) | Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos | |
FI861410A0 (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva aminopropanolderivat. | |
FR2432519A1 (fr) | Nouveaux derives de purine et medicament les contenant | |
FR2363330A1 (fr) | Medicament destine a reduire la fertilite chez les mammiferes | |
ES472847A1 (es) | Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion | |
DE3462894D1 (de) | 3-indolecarboxamide compounds | |
ATE41772T1 (de) | Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen. | |
ES455691A1 (es) | Procedimiento para la produccion de derivados de piperacina. | |
FR2362849A1 (fr) | Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant | |
KR890005107A (ko) | 약제 제조를 위한 특정 6-머캅토푸린의 용도 및 이 약제의 제조방법 | |
KR890012942A (ko) | 5-치환된 오르니틴 유도체 | |
KR880001596A (ko) | 디하이드로피리딘 화합물-함유 뇌기능이상 치료제 | |
PT77666A (fr) | Procede de preparation de nouveaux derives de la nitrosouree | |
KR880004810A (ko) | 소화성 궤양 치료제 | |
KR900701273A (ko) | 진토성 에르골린 유도체 | |
EP0093497A3 (en) | Anthelmintic treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |